logo
Select company
Select metric
$ -0.46EBITDA per Share
VS
Market
25
Sector
61
Industry
45
History
18
$ 0.51Close
$ 0.24 - $ 2.44 52-Week Range
Ticker Information

Ticker

PRPH

Company Name

PROPHASE LABS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

PROPHASE LABS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PRPH - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -19.15M$ -0.46141.54M
3/31/2025$ -23.55M$ -0.67135.23M
12/31/2024$ -36.17M$ -1.77120.46M
9/30/2024$ -27.25M$ -1.43119.08M
6/30/2024$ -26.43M$ -1.4118.89M
3/31/2024$ -23.5M$ -1.3118.05M
12/31/2023$ -14.83M$ -0.86117.21M
9/30/2023$ -9.64M$ -0.56117.18M
6/30/2023$ -1.69M$ -0.1116.84M
3/31/2023$ 13.41M$ 0.8116.75M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROPHASE LABS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -0.11.
  • Over the past 5 years, PROPHASE LABS INC's average EBITDAPS has been $ 0.07.
  • The median EBITDAPS for PROPHASE LABS INC during this period was $ -0.11
  • PROPHASE LABS INC reached its highest EBITDAPS over the past 5 years at $ 2.76.
  • The lowest EBITDAPS recorded by PROPHASE LABS INC in the same timeframe $ -1.77

PROPHASE LABS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
BNBX : APPLIED DNA SCIENCES INC $ -22.47INBS : INTELLIGENT BIO SOLUTIONS INC $ -1.76TNON : TENON MEDICAL INC $ -1.59TRAW : TRAWS PHARMA INC $ 15.1TXMD : THERAPEUTICSMD INC $ -0.01LGVN : LONGEVERON INC $ -1.16BOLT : BOLT BIOTHERAPEUTICS INC $ -24.58LPCN : LIPOCINE INC $ -0.83CYCN : CYCLERION THERAPEUTICS INC $ -0.63XAIR : BEYOND AIR INC $ -7.15

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for PROPHASE LABS INC is calculated as follows: EBITDA [ $ -1.26M ] / (Shares WA [ 11.6M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -0.11 ]

PRPH - EBITDA per Share, Last 5 years

$ -1.77

Minimum

Dec 31, 2024

$ 2.76

Maximum

Sep 30, 2022

$ 0.07

Average

$ -0.11

Median

EBITDAPS Benchmark Analysis

The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 14.03
average$ 2.03
median$ 1
std$ 4.28